we joining was their Saqib. stellar Thanks, and Good for in and worldwide physician revenue physician and new year attained customers you patients thank delivered as a us. XXXX SI-BONE, record our afternoon, for engagement. heights
XX% was performance year full as For X,XXX revenue compared of led year generated million, the reflecting the XX,XXX more performed procedures. physicians U.S. full than U.S. XXXX. worldwide XXXX, over by growth $XXX.X This robust we to demand worldwide
XXXX with revenue We of an started $XXX to expectation million initial $XXX million.
demand our clearly differentiated national the highly exceed our increases February. physician With allowed expectation. in solutions, growing the evident strong for business significantly to sales meeting surgical and capacity that momentum was our us at in The engagement in
about potential enthusiastic XXXX even by but of energized more only opportunity our not was performance the XXXX. organization in sales Our us in ahead was
future Having can in the been been I mood the company years, has for company in the X at say confidence the and stronger. our almost never
in drove building adjusted approximately EBITDA operating XX% fiscal discipline XXXX. scalable year Our improvement last in infrastructure methodical years over foresight in in and few the fashion
XXXX. usage cash portfolio invest expansion and while our the in reduced in evidence also We R&D support to to clinical planned continuing
as XXXX, procedure company, first volume update growth our on priorities, provide I'd given across annual multiple year I the transformed is a nearly per solving team. getting a our recognize million like started an sacropelvic deliver unmet our XX% X.X We company cumulative multiproduct We're strategic a testament to work. Working needs into target is to your clinical year. to since public that just procedures hard Before together U.S. procedures.
customers focus and our delivering Your revenue on large market us and sustainable opportunity is for growth. allowing to this deliver strong capture
me year key experience strong has look with deliver sales managers. as a we complement our agents manager sales initiatives provide third-party as proud position and of us We're Starting for target with our coverage. of industry-leading several extend bandwidth leadership growth. U.S. an our record markets. update territory growing We ended allowed and expertise build their new quarters long-term let markets known We team our Now XX extremely as infrastructure. support and to network on drive commercial execution and Their with our territory to of revenue. sales case well quota-carrying clinical specialists extensive for across the
strategy to we closer revenue revenue to well million, territory hybrid prior end compared time. of $X in and continue revenue was has worked ability over $X.X see our per to This In increase territory. XXXX, confident to the in per as reflecting further target our get million We're growth the per growth $X.X high to XX% year. million territory
plan to to the territory over expanded engagement $X few growing our footprint and facilitate with addressable enable will the territory productivity, territories billion potential capture total over add The to we opportunity. to our years. to us of market addition portfolio deeper selectively growing next XX our physicians In maximize the
forward-looking long-term the the and a quarter consecutive elevated trajectory over underscores growth business. physicians, exited physicians year in This quarter prior year-over-year We growth great physician quarter double-digit nearly positions is the the The period. interest increase XXth an quarter to of to XXX the with engagement. was XXXX of in active and growth. our the U.S. fourth of active X,XXX physician indicator of XX% engagement over on of compared level Moving active fourth
interventional SI suffering joint provide medium-term pain relief; durable which ranging long-term surgical pain care, from can types of procedures management Patients undergo procedures, can and dysfunction relief; nonsurgical different for short-term relief. from provide that
from procedures cortical particularly SI allograft. stabilization few the years, joint for increase an interest interventionalists, last bone in Over we've seen in
surgeons today fusion growing physicians radiologists, with interventional will spine anesthesiologists, spine XX% the as joint believe interest specialists medicine opportunity. as less interventional our this capture which SI the ability space, to We and the with well accelerate our this and interventional in engagement expanded that our and physical Given include market the market we've rehabilitation penetrated than is physicians, partnership specialty.
using months, skilled spine the we've a experience been last targeting Over prior who trained our of and X,XXX highly We've interventionalists subset lateral other XX the estimated invasive engaged U.S. the in minimally have interventionalists in technique iFuse-TORQ. with procedures.
early, the we're of still of level encouraged trained of we adoption. have the caliber While pace interventionalists and their by interest,
The an STACI is a study, XXXX. In initiated iFuse-TORQ we part dysfunction patients in on prospective the we the which early also evidence important enrollment use XXXX, of by with always SI-BONE'S its to study expect commitment been and of by is the results to and physicians. Clinical joint has publish ongoing, June of end sacroiliac interventionalists. patients
broad leader, engagement. expertise, evidence training market the force our clinical strong believe are and sales product that we are portfolio, As clear differentiators interventional to that experienced leading
as forward, physician to and engage expect target strong remain Going X,XXX surgeons the we active X,XXX we nearly growth interventionalists. target
expect our per increase clinical product procedure also and time. to deeper over drive engagement evidence We publish physician and growing portfolio
Solutions. Turning to Products and
experienced In each U.S. of XXXX, further clinical volume products needs leadership to a procedure we've robust demonstrated products the techniques launching target the in address record value growth extend outcome. and surgical we're new patient innovative building of and our unmet have in our We substantiates innovation. markets to track our The improve of position.
X, intra-articular joint January Within reimbursed the the with code implant, AMA comprehensive most Effective posterior approach. adopted to allograft iFuse for XXXX, CPT a minimally procedure separate XXXXX. SI XD placed a CPT using degeneration, typically bone joint cortical physicians sacroiliac and invasive a directly from procedures in performed dysfunction code XXXXX an minimally joint describe provide SI X in a under the iFuse-TORQ invasive solutions fusion
more I by is earlier, interventional spine shared commonly physician. As this technique used
INTRA. iFuse available the procedure XXXX the which Bone, into CPT coverage enhanced include builds iFuse both that With interventionalist INTRA posterior enable approach. surgical from with facility with using techniques new product, office-based placement our also and iFuse joint accurate expanded established some training XXXXX launched was we to for the new and of allograft our payers, likely code a implant on in
recently multiple now and INTRA, We office-based their treatment references. procedure the lab iFuse completed setting. interventionalists address an we iFuse to INTRA in first products offer With iFuse-TORQ
strong pelvic growing foundation at and care fixation long of to joint, interest, breakthrough our fixation. of for procedures. device believe a adult on we adoption demand the iFuse SI standard the surgeon strong Moving Based can become the the of infusion construct deformity Granite Bedrock base providing
pain highlighted prevalence as fixation underscoring the inclusion publication SI undergoing joint part XX% patients SILVIA of surgery, further A spinal of with infusion procedures. of pelvic deformity for the the in need these results of recent early
diameter X.X-millimeter indication. of end clearance line pediatric for the XXX(k) January, implant and the FDA we Granite the from received with On the deformity extension SX at
constructs, Granite approximately spine level launched Since case to SI are in XX%. X volume has X on our shorter surgeries Granite XXXX, been was Based in be level generally joint fusion estimated shorter which is postoperative published procedures. up data, in to incidents degenerative of XX% to
pelvic high fusion revision other patients incidents, underlying or loosening due high bone a BMI. of lumbar shorter and conditions to undergoing Additionally, osteoporotic as risk level some at are procedures such screw hardware higher from failure
diameter the The that the second including We current procedures high-risk the spine interest in plan diameter end the provide deformity of increasing level as diameter implant sacrum surgeons a expressed procedures We as Granite pelvic the implant. and an the in fusion at launch Granite degenerative engage smaller adoption fixation surgeon believe shorter a annual XXX,XXX larger approximately in offering the for community these the preference will the who smaller of for diameter well among illustrates implant smaller quarter. have patients. availability to
a we've We're market the to another the XXXX, the made thought pace for XXXX, iFuse-TORQ adoption launch the leaders We over encouraged by sacral of we end product, with the XX last treating develop SAFFRON the will trauma for new insufficiency major patients. treating combined pelvic initial with opportunity. the believe from key these are months market. in late In surgery, fractures. Toward trauma trauma will progress of the center targeting to engaged capturing trauma significant results be trial product
be call our Anshul XXX,XXX year that, driver and the insufficiency sacral for XX% rate market us. growth the financial for to long-term are With will discuss over who X-year of patients to a crucial a hand mortality with fractures to the over performance. With I'll treated trauma Bedrock, up
